THE MUST-HAVE NEONATAL DRUG INFORMATION RESOURCE
More than 430,000 premature babies are admitted to neonatal intensive care units (NICU) each year. Because commercially available drugs are not tested on infants in the United States, more than 90 percent of the drugs prescribed to them are off-label. Consequently, neonatal drug dosing and parenteral nutrition ordering are among the most complex and error-prone in healthcare today.
Thomson Reuters NeoFax® is designed to help clinicians accurately prescribe, calculate, formulate, and administer essential drugs and parenteral nutrition solutions for infants.
By providing complete neonatal drug information covering more than 180 substances, NeoFax helps reduce medication errors and decreases time spent ordering and compounding.
NEOFAX IS THE ONLY SINGLE-SOURCE PROVIDER OF:
| • | Trusted, evidence-based neonatal drug information |
| • | Comprehensive infant formula information presented in a user-configurable side-by-side display |
| • | Comprehensive neonatal drug dose calculation module |
| • | Safe and efficient parenteral nutrition order entry system |